LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Andrea Eastman <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Sat, 6 Apr 2002 23:36:01 -0500
Content-Type:
text/plain
Parts/Attachments:
text/plain (39 lines)
Hi,

I received the following from the FDA Medwatch program.

Warmly,
Andrea Eastman, MA, IBCLC
Granville, Ohio

--


MedWatch: The FDA Safety Information and Adverse Event Reporting Program

The FDA Center for Food Safety and Applied Nutrition (CFSAN) notified
healthcare professionals and consumers of the potential risk of severe
liver
injury associated with the use of kava-containing dietary supplements.
Supplements containing the herbal ingredient kava are promoted for
relaxation (e.g., to relieve stress, anxiety, and tension),
sleeplessness,
menopausal symptoms and other uses. Kava-containing products have been
associated with liver-related injuries, including hepatitis, cirrhosis,
and
liver failure. Given these reports, persons who have liver disease or
liver
problems, or persons who are taking drug products that can affect the
liver,
should consult a physician before using kava-containing supplements.

See the MedWatch 2002 Safety Information entry at:

http://www.fda.gov/medwatch/SAFETY/2002/safety02.htm#kava

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2